Orphanet Journal of Rare Diseases was recently accepted for tracking by Thomson Reuters. It is included in the ISI Web of Knowledge database and will receive its first impact factor this summer. We are delighted with this
achievement, which confirms the prominence and reputation which Orphanet Journal of Rare Diseases  has achieved in its field.

The journal was launched in 2006 and has since
published a wide range of open access articles
concerning rare diseases and orphan drugs. Overseen by Ségolène Aymé, Bruno Dallapiccola
and Dian Donnai, the journal is the official publication of Orphanet, the European
portal for rare diseases and orphan drugs.

Orphanet
Journal of Rare Diseases is one of eleven BioMed Central titles that are
due to receive their first impact factors in June 2008; a full list of all of the BioMed Central
journals that are indexed by Thomson Reuters is available from our website.